SCHEDULE 13G/A: Empyrean Capital Partners Discloses 9.8% Stake in Churchill Capital Corp IX

Empyrean Capital Partners, LP and Amos Meron have disclosed a beneficial ownership of 9.8% of Churchill Capital Corp IX's Class A Ordinary Shares, totaling 2,900,000 shares, as of December 31, 2024.

Summary

• Empyrean Capital Partners, LP (ECP) and Amos Meron (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
• The filing reports beneficial ownership of 2,900,000 Class A Ordinary Shares of Churchill Capital Corp IX.
• This ownership represents 9.8% of the total Class A Ordinary Shares outstanding.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• The percentage is calculated based on 29,475,000 Class A Ordinary Shares outstanding as of November 13, 2024, as reported in the Company's Form 10-Q.
• ECP serves as the investment manager to Empyrean Capital Overseas Master Fund, Ltd. (ECOMF), which directly holds the shares.
• Amos Meron is the managing member of Empyrean Capital, LLC, the general partner of ECP.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a significant stake by an institutional investor can be interpreted as a vote of confidence in the company, even though the filing itself is purely factual and regulatory.

Positives

• The disclosure of a significant stake (9.8%) by an institutional investor like Empyrean Capital Partners may be viewed positively by the market, indicating confidence in Churchill Capital Corp IX.
• The filing explicitly states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control, which can reduce concerns about potential activist investor actions.

Risks

• The document does not disclose any specific risks related to Churchill Capital Corp IX's operations or financial health. It is a beneficial ownership filing focused on the reporting party's holdings and intent.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Churchill Capital Corp IX's future outlook.

Management Comments

• The Reporting Persons certify that, to the best of their knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor. It does not provide specific insights into broader industry trends or competitive landscape, beyond indicating an investment in a SPAC (Special Purpose Acquisition Company) or a company that was a SPAC.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant institutional ownership stake, which can influence market perception and potentially share price.

Key Dates

Keywords

Churchill Capital Corp IX, Empyrean Capital Partners, Amos Meron, Schedule 13G, Beneficial Ownership, Class A Ordinary Shares, Institutional Investor, SEC Filing, Investment Management